Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;12(2):1494-508.
doi: 10.3390/s120201494. Epub 2012 Feb 3.

Miniaturized protein microarray with internal calibration as point-of-care device for diagnosis of neonatal sepsis

Affiliations

Miniaturized protein microarray with internal calibration as point-of-care device for diagnosis of neonatal sepsis

Patricia Buchegger et al. Sensors (Basel). 2012.

Abstract

Neonatal sepsis is still a leading cause of death among newborns. Therefore a protein-microarray for point-of-care testing that simultaneously quantifies the sepsis associated serum proteins IL-6, IL-8, IL-10, TNF alpha, S-100, PCT, E-Selectin, CRP and Neopterin has been developed. The chip works with only a 4 μL patient serum sample and hence minimizes excessive blood withdrawal from newborns. The 4 μL patient samples are diluted with 36 μL assay buffer and distributed to four slides for repetitive measurements. Streptavidin coated magnetic particles that act as distinct stirring detection components are added, not only to stir the sample, but also to detect antibody antigen binding events. We demonstrate that the test is complete within 2.5 h using a single step assay. S-100 conjugated to BSA is spotted in increasing concentrations to create an internal calibration. The presented low volume protein-chip fulfills the requirements of point-of-care testing for accurate and repeatable (CV < 14%) quantification of serum proteins for the diagnosis of neonatal sepsis.

Keywords: internal calibration; miniaturization; neonatal sepsis; point-of-care testing; protein microarray; streptavidin coated magnetic particles.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
On-chip sandwich immunoassay steps for (a) the classical chip (b) the miniaturized chip and (c) the optimized miniaturized chip. Capture antibodies are immobilized equally providing same array format for the classical chip and the miniaturized chip. a(I) incubation of analytes (2.5 h), a(II) incubation of biotinylated detection antibodies (45 min), a(III) detection of bound antigens/antibodies via Dy647 Streptavidin incubation (45 min); b(I) Incubation of analytes, biotinylated antibodies and streptavidin conjugated magnetic particles in one step (2.5), b(II) detection via biotinylated antibody against Cy3/Cy5 and Cy3 labeled streptavidin; c(I) Incubation of analytes, biotinylated antibodies and Dy647 Streptavidin conjugated magnetic particles in one step (2.5 h).
Figure 2.
Figure 2.
Calibration curves for (a) IL-6 (b) S-100 (c) E-Selectin and (d) CRP. The black curve ( formula image) displays the 10 μL assay and the red curve ( formula image) shows the 50 μL assay when adding strep.MPs; the blue curve ( formula image) displays the classical 50 μL assay and the green curve ( formula image) displays the 10 μL assay without addition of strep.MPs.
Figure 3.
Figure 3.
Calibration curves for (a) IL-6 (b) S-100 (c) E-Selectin and (d) CRP in human serum 1:10 diluted with assay buffer after 2.5 h ( formula image), 2 ( formula image) and 1.5 h ( formula image) processing time.
Figure 4.
Figure 4.
Calibration curves (a) and Scatter plot (b) for the internal ( formula image) and external chip calibration ( formula image). Internal and external calibration curves cover a very similar measurement range and most fluorescence intensity values cluster within the 95% confidence band (grey dotted lines) of the fit line. The coefficient of determination (R2) was 0.968.
Figure 5.
Figure 5.
Processed chip showing spots obtained for the external (a) and internal (b) calibration at a concentration of 8.1 ng/mL S-100.

References

    1. Qazi S.A., Stoll B.J. Neonatal sepsis: A major global public health challenge. Pediatr. Infect. Dis. J. 2009;28:S1–S2. - PubMed
    1. Junker R., Schlebusch H., Luppa P.B. Point-of-care testing in hospitals and primary care. Dtsch. Arztebl. Int. 2010;107:561–567. - PMC - PubMed
    1. Marlowe E.M., Gibson L., Hogan J., Kaplan S., Bruckner D.A. Conventional and molecular methods for verification of results obtained with BacT/Alert Nonvent blood culture bottles. J. Clin. Microbiol. 2003;41:1266–1269. - PMC - PubMed
    1. Sankar M.J., Agarwal R., Deorari A.K., Paul V.K. Sepsis in the newborn. Indian J. Pediatr. 2008;75:261–266. - PubMed
    1. Wiesinger-Mayr H., Vierlinger K., Pichler R., Kriegner A., Hirschl A.M., Presterl E., Bodrossy L., Noehammer C. Identification of human pathogens isolated from blood using microarray hybridisation and signal pattern recognition. BMC Microbiol. 2007 doi: 10.1186/1471-2180-7-78. - DOI - PMC - PubMed

Publication types

LinkOut - more resources